A novel, noninvasive, predictive epilepsy biomarker with clinical potential

91Citations
Citations of this article
142Readers
Mendeley users who have this article in their library.

Abstract

A significant proportion of temporal lobe epilepsy (TLE), a common, intractable brain disorder, arises in children with febrile status epilepticus (FSE). Preventative therapy development is hampered by our inability to identify early the FSE individuals who will develop TLE. In a naturalistic rat model of FSE, we used high-magnetic-field MRI and long-term video EEG to seek clinically relevant noninvasive markers of epileptogenesis and found that reduced amygdala T2 relaxation times in high-magnetic-field MRI hours after FSE predicted experimental TLE. Reduced T2 values likely represented paramagnetic susceptibility effects derived from increased unsaturated venous hemoglobin, suggesting augmented oxygen utilization after FSE termination. Indeed, T2 correlated with energy-demanding intracellular translocation of the injury-sensor high-mobility group box 1 (HMGB1), a trigger of inflammatory cascades implicated in epileptogenesis. Use of deoxyhemoglobin-sensitive MRI sequences enabled visualization of the predictive changes on lower-field, clinically relevant scanners. This novel MRI signature delineates the onset and suggests mechanisms of epileptogenesis that follow experimental FSE. © 2014 the authors.

Cite

CITATION STYLE

APA

Choy, M. K., Dubé, C. M., Patterson, K., Barnes, S. R., Maras, P., Blood, A. B., … Baram, T. Z. (2014). A novel, noninvasive, predictive epilepsy biomarker with clinical potential. Journal of Neuroscience, 34(26), 8672–8684. https://doi.org/10.1523/JNEUROSCI.4806-13.2014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free